Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma Read more
Chemotherapy uptake to gradually decrease with arrival of novel therapies and biosimilars- GlobalData Read more